Logo image of GMED

GLOBUS MEDICAL INC - A (GMED) Stock News

NYSE:GMED - New York Stock Exchange, Inc. - US3795772082 - Common Stock - Currency: USD

93.12  +0.33 (+0.36%)

After market: 93.12 0 (0%)

GMED Latest News, Press Releases and Analysis

News Image
4 hours ago - Globus Medical

Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

AUDUBON, Pa., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its...

News Image
2 days ago - Chartmill

Why NYSE:GMED is Poised for High Growth.

A fundamental and technical analysis of (NYSE:GMED): Exploring GLOBUS MEDICAL INC - A (NYSE:GMED)'s high growth characteristics.

News Image
18 days ago - Investor's Business Daily

Stryker Had A Good Year Last Year; Here's How It's Looking For 2025

Reflecting its strong growth, on Monday the Relative Strength (RS) Rating for Stryker stock got an upgrade from 70 to 74.

News Image
22 days ago - Globus Medical

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

AUDUBON, Pa., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced...

News Image
23 days ago - Investor's Business Daily

Inspire Medical's Sleep Innovations Driving Big Gains

Inspire Medical, which makes innovative apnea relief devices, hit a key performance benchmark as its Relative Strength Rating jumped to 81.

News Image
24 days ago - Investor's Business Daily

Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devices

Lantheus Holdings sees its Relative Strength Rating reach the 80-plus level.

News Image
2 months ago - Investor's Business Daily

Inari Medical Stock Gets RS Rating Upgrade

On Wednesday, Inari Medical stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72.

News Image
2 months ago - Investor's Business Daily

Novocure Stock Earns 96 RS Rating

On Tuesday, Novocure stock got a positive adjustment to its Relative Strength (RS) Rating to 96, up from 73.

News Image
2 months ago - Globus Medical

Globus Medical Launches ExcelsiusHubâ„¢ Navigation System

AUDUBON, Pa., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the...

News Image
3 months ago - The Motley Fool

Globus Medical (GMED) Q3 2024 Earnings Call Transcript

GMED earnings call for the period ending September 30, 2024.

News Image
3 months ago - Globus Medical

Globus Medical Reports Third Quarter 2024 Results

AUDUBON, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its...

News Image
3 months ago - Globus Medical

Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting

AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the...

News Image
4 months ago - Globus Medical

Globus Medical Schedules Third Quarter Earnings Release and Conference Call

AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its...

News Image
4 months ago - Globus Medical

Globus Medical Launches the Next Wave of Orthopedic Trauma Solutions

AUDUBON, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announces the continued...

News Image
4 months ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company") (NYSE: GMED). Such investors...

News Image
5 months ago - Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company") (NYSE: GMED). Such investors...